Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders

Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders

US Patent 7390823 · Granted Jun 24, 2008

Estimated economic value: $10,665,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof2009
Piperidine derivatives, process for obtaining them and pharmaceutical compositio2005
1-Phenacyl-3-phenyl-3-(piperidylethyl)piperidine derivatives, process for the pr2003
Use of saredutant for the treatment of adaptation, bipolar, and dysthymic disord2003
Use of saredutant for the treatment of adaptation, bipolar, and dysthymic disord2003
Use of saredutant for the treatment of adaptation, bipolar, and dysthymic disord2003
Morpholine derivatives, method for the production thereof and pharmaceutical pre2003
Ureidopiperidine derivatives as selective human NK3 receptor antagonists2002
Osanetant in the treatment of depression and depressive disorders2002
Osanetant in the treatment of depression and depressive disorders2002
Osanetant in the treatment of depression and depressive disorders2002
Use of central cannabinoid receptor antagonists for regulating appetence2002